NCR Online Journal

Press Release

Dimethylformamide (DMF) Market Set to Flourish with Anticipated Worth of $2.7 Billion by 2027

Browse 261 market data Tables and 38 Figures spread through 205 Pages and in-depth TOC on “Dimethylformamide (DMF) Market” Dimethylformamide (DMF) Market by Type (Reactant and Feedstock), End-use industries (Chemicals,

Read Full Article

Personal Cloud Market Growth, Opportunities Business Scenario, Share, Growth Size, Scope, Key Segments and Forecast to 2027

Alphabet Inc, (US), Microsoft Corporation (US), Apple Inc. (US), Dropbox, Inc. (US), Amazon Web Services, Inc. (US), Box (US), Seagate Technology LLC (US), Western Digital Corporation (US), Synchronoss Technologies, Inc.

Read Full Article

Anticipated Growth in Hand Eczema Market Projected during Forecast Period (2023-2032) by DelveInsight | Companies – Leo Pharma, Asana Biosciences, Regeneron, Sanofi, Incyte

Hand Eczema Market (Albany, USA) DelveInsight’s “Hand Eczema Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Hand Eczema, historical and forecasted epidemiology as well as the Hand

Read Full Article

Exploring the Gout Pipeline in 2023: FDA Approvals, Promising Therapies, and Key Players Identified by DelveInsight | TaiwanJ Pharmaceuticals, Nippon Chemiphar, HemoShear & Horizon Therapeutics plc

Gout Pipeline (Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Gout pipeline constitutes 40+ key companies continuously working towards developing 40+ Gout treatment therapies, analysis of Clinical Trials,

Read Full Article

Latest Updates on Myopia Pipeline Analysis in 2023: Recent FDA, EMA, and PMDA Approvals Explored by Pfizer, ALCON Inc., Bausch Health Companies Inc., Essilor Luxottica, and Johnson & Johnson

Myopia Pipeline (Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Myopia pipeline constitutes 10+ key companies continuously working

Read Full Article

Exploring the Landscape of Acute Kidney Injury Pipeline Drugs 2023: FDA Approvals, Clinical Trials, Therapies, Mechanism of Action, & ROA Unveiled by DelveInsight | Atox Bio, AM Pharma Holding, QuarK

Acute Kidney Injury Pipeline (Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Acute Kidney Injury pipeline constitutes 30+

Read Full Article

Chronic Refractory Cough Pipeline Drugs Update (2023) – FDA Approvals, Clinical Trials, Therapies, Mechanism of Action, Administration Routes by DelveInsight | Focus on Genentech and Trevi

Chronic Refractory Cough Pipeline (Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Chronic Refractory Cough pipeline constitutes key

Read Full Article

Exploring Acute Myeloid Leukemia Pipeline and Clinical Trials 2023: FDA Approvals, Therapeutic Advances, Companies Analyzed by DelveInsight | SystImmune, Jasper Therapeutics, Chimerix, Akeso Biopharma

Acute Myeloid Leukemia Pipeline (Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Acute Myeloid Leukemia pipeline constitutes 260+

Read Full Article

Pancreatic Ductal Adenocarcinoma Pipeline, FDA Approvals, Clinical Trials Developments, and Companies 2023 | Alligator Bioscience, Cardiff Oncology, Novartis, and others.

DelveInsight’s, “Pancreatic Ductal Adenocarcinoma Pipeline Insight 2023” report provides comprehensive insights about 80+ companies and 80+ pipeline drugs in Pancreatic

Read Full Article

Ocular Hypertension Pipeline, FDA Approvals, Clinical Trials Developments and Companies 2023 | Nicox, Qlaris Bio, TheratOcular Biotek Co., Ltd., Ocular Therapeutix, Whitecap Biosciences, and others.

DelveInsight’s, “Ocular Hypertension Pipeline Insight 2023” report provides comprehensive insights about 70+ companies and 75+ pipeline drugs in the Ocular

Read Full Article